Get the Stockscreener App
1.06
7.02%
-0.08
After Hours:
1.07
0.01
+0.94%
Neurosense Therapeutics Ltd stock is traded at $1.06, with a volume of 272.48K.
It is down -7.02% in the last 24 hours and down -42.70% over the past month.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
See More
Previous Close:
$1.14
Open:
$1.11
24h Volume:
272.48K
Relative Volume:
0.78
Market Cap:
$28.48M
Revenue:
-
Net Income/Loss:
$-13.76M
P/E Ratio:
-1.1398
EPS:
-0.93
Net Cash Flow:
-
1W Performance:
-9.63%
1M Performance:
-42.70%
6M Performance:
-0.93%
1Y Performance:
+39.47%
1-Day Range:
$1.04
$1.12
1-Week Range:
$1.04
$1.1882
52-Week Range:
$0.73
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Name
Neurosense Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare NRSN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
1.06 | 28.48M | 0 | -13.76M | 0 | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Neurosense Therapeutics Ltd Stock (NRSN) Latest News
NeuroSense Therapeutics Ltd. stock daily chart insightsEarnings Trend Report & Capital Efficient Trade Techniques - Newser
Will NeuroSense Therapeutics Ltd. Equity Warrant outperform the marketStop Loss & Low Drawdown Investment Strategies - Newser
Real time social sentiment graph for NeuroSense Therapeutics Ltd.July 2025 Technicals & Technical Pattern Alert System - Newser
Is NeuroSense Therapeutics Ltd. Equity Warrant still worth holding after the dip2025 Top Gainers & Risk Managed Trade Strategies - Newser
What the charts say about NeuroSense Therapeutics Ltd. Equity Warrant todayJuly 2025 Technicals & Daily Entry Point Alerts - Newser
Analyzing recovery setups for NeuroSense Therapeutics Ltd. Equity Warrant investorsQuarterly Trade Summary & Daily Price Action Insights - Newser
Tools to assess NeuroSense Therapeutics Ltd.’s risk profileEarnings Performance Report & Daily Oversold Stock Bounce Ideas - Newser
Has NeuroSense Therapeutics Ltd. found a price floorJuly 2025 Fed Impact & AI Optimized Trading Strategy Guides - Newser
Is NeuroSense Therapeutics Ltd. forming a bottoming baseEntry Point & Stock Market Timing Techniques - Newser
How to use Fibonacci retracement on NeuroSense Therapeutics Ltd.Weekly Trade Analysis & Accurate Buy Signal Alerts - Newser
Is NeuroSense Therapeutics Ltd. Equity Warrant trending in predictive chart modelsJuly 2025 Earnings & Entry and Exit Point Strategies - Newser
Long term hold vs stop loss in NeuroSense Therapeutics Ltd.Gap Up & Free Fast Entry Momentum Trade Alerts - Newser
What’s next for NeuroSense Therapeutics Ltd. Equity Warrant stock priceEarnings Overview Report & Weekly Breakout Watchlists - Newser
Using R and stats models for NeuroSense Therapeutics Ltd. forecastingPrice Action & AI Forecasted Entry/Exit Points - Newser
Full technical analysis of NeuroSense Therapeutics Ltd. stockJuly 2025 Setups & High Yield Equity Trading Tips - Newser
Automated trading signals detected on NeuroSense Therapeutics Ltd.July 2025 Momentum & Expert Curated Trade Setup Alerts - Newser
Published on: 2025-08-30 22:30:22 - Newser
Using flow based indicators on NeuroSense Therapeutics Ltd. Equity Warrant2025 Price Momentum & Expert Approved Trade Ideas - Newser
Historical volatility pattern of NeuroSense Therapeutics Ltd. visualized2025 Technical Overview & Accurate Intraday Trade Tips - Newser
Forecasting NeuroSense Therapeutics Ltd. Equity Warrant price range with options data2025 Market WrapUp & High Accuracy Swing Entry Alerts - Newser
Will NeuroSense Therapeutics Ltd. Equity Warrant stock go up soonJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Reversal indicators forming on NeuroSense Therapeutics Ltd. stockMarket Rally & Weekly Breakout Opportunity Watchlist - Newser
Full technical analysis of NeuroSense Therapeutics Ltd. Equity Warrant stockWeekly Profit Recap & Real-Time Stock Price Movement Reports - Newser
NeuroSense Therapeutics Ltd. Equity Warrant Hits Price Floor — Bounce IncomingEarnings Trend Report & Technical Pattern Recognition Alerts - beatles.ru
NeuroSense Therapeutics Ltd. stock trendline breakdownDollar Strength & AI Optimized Trade Strategies - Newser
Measuring NeuroSense Therapeutics Ltd. Equity Warrant’s beta against major indices2025 Geopolitical Influence & Weekly High Momentum Picks - Newser
How to recover losses in NeuroSense Therapeutics Ltd. stock2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Applying Elliott Wave Theory to NeuroSense Therapeutics Ltd. Equity Warrant2025 Winners & Losers & Verified Technical Signals - Newser
Will NeuroSense Therapeutics Ltd. Equity Warrant stock recover after recent dropJuly 2025 Rallies & Technical Analysis for Trade Confirmation - Newser
Risk adjusted return profile for NeuroSense Therapeutics Ltd. analyzedQuarterly Earnings Report & Risk Managed Investment Strategies - Newser
NeuroSense Therapeutics Ltd.’s volatility index tracking explainedWeekly Trend Report & AI Enhanced Market Trend Forecasts - Newser
Published on: 2025-08-30 01:21:45 - Newser
Is this a good reentry point in NeuroSense Therapeutics Ltd. Equity WarrantQuarterly Trade Summary & Verified Momentum Stock Ideas - Newser
How to use a screener to detect NeuroSense Therapeutics Ltd. breakoutsTrade Exit Summary & Entry Point Confirmation Alerts - Newser
Will breakout in NeuroSense Therapeutics Ltd. Equity Warrant lead to full recoveryJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Market reaction to NeuroSense Therapeutics Ltd.’s recent news2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
Is it time to cut losses on NeuroSense Therapeutics Ltd. Equity WarrantWeekly Investment Summary & Real-Time Market Sentiment Reports - Newser
Intraday pattern recognizer results for NeuroSense Therapeutics Ltd.July 2025 Patterns & Fast Entry and Exit Trade Plans - Newser
Should you hold or exit NeuroSense Therapeutics Ltd. now2025 Market WrapUp & Daily Profit Maximizing Trade Tips - Newser
Neurosense Therapeutics Ltd Stock (NRSN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):